Founded in Science.
Leveraging our flexible platform for massively parallel oligo synthesis, we offer affordable solutions for today’s genomics research needs, including powerful custom tools for targeted next-generation sequencing and cytogenomics.
Cell-free protein expression has become a popular tool in many biology fields ranging from synthetic biology to industrial biomanufacturing. We provide high-quality, consistently performing products for projects of any scale to researchers around the world. Our experienced scientists are available to assist with designing and optimizing your custom synthetic biology project.
We have combined the best of oligonucleotide chemistry with a simple yet highly flexible synthesis format, which allows production of fully customized, high-quality oligo libraries and microarrays at a low cost compared to other manufacturers. Learn more about our offerings for research or development applications.
Webinar on July 29, 2021
The liquid biopsy potential of cell-free DNA (cfDNA) has gained increasing interest and attention for screening, diagnosis, treatment, and monitoring in the spectrum of human malignancies. Recent studies show that epigenetic markers can be more clinically informative than other quantitative cfDNA detection methods. The most common epigenetic DNA modification in humans is the alteration of the methylation status of cytosines.
Our speaker, Bodour Salhia, Ph.D., Associate Professor, Keck School of Medicine, University of Southern California, will discuss a cfDNA methylation biomarker discovery and validation process that can be broadly applied in designing assays for the detection of early and residual cancer.